{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:51:02Z","timestamp":1787496662251,"version":"build-2736575974"},"posted":{"date-parts":[[2023,7,16]]},"group-title":"Genetic and Genomic Medicine","reference-count":31,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,7,16]]},"abstract":"<jats:title>STRUCTURED ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Importance<\/jats:title>\n                  <jats:p>The reported phenotypes of men with 47,XXY and 47,XYY syndromes include tall stature, multisystem comorbidities, and poor health-related quality of life (HRQoL). However, knowledge about these sex chromosome aneuploidy (SCA) conditions has been derived from studies in the &lt;15% of patients who are clinically diagnosed and also lack diversity in age and genetic ancestry.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Determine the prevalence of clinically diagnosed and undiagnosed X or Y chromosome aneuploidy among men enrolled in the Million Veteran Program (MVP); describe military service metrics of men with SCAs; compare morbidity and mortality outcomes between men with SCA with and without a clinical diagnosis to matched controls.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Cross-sectional, case-control<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>United States Veterans Administration Healthcare System<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>Biologic males enrolled in the MVP biobank with genomic identification of an additional X or Y chromosome (cases); controls matched 1:5 on sex, age, and genetic ancestry<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Main Outcome(s) and Measure(s)<\/jats:title>\n                  <jats:p>Prevalence of men with SCAs from genomic analysis; clinical SCA diagnosis; Charlson Comorbidity Index (CCI); rates of outpatient, inpatient, and emergency encounters per year; self-reported health outcomes; standardized mortality ratio (SMR)<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>An additional X or Y chromosome was present in 145 and 125 per 100,000 males in the MVP, respectively, with the highest prevalence among men with European and East Asian ancestry. At a mean age of 61\u00b112 years, 74% of male veterans with 47,XXY and &gt;99% with 47,XYY remained undiagnosed. Individuals with 47,XXY (n=862) and 47,XYY (n=747) had similar military service history, all-cause SMR, and age of death compared to matched controls. CCI and healthcare utilization were higher among individuals with SCA, while several measures of HRQoL were lower. Men with a clinical diagnosis of 47,XXY had higher healthcare utilization but lower comorbidity score compared to those undiagnosed.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion and Relevance<\/jats:title>\n                  <jats:p>One in 370 males in the MVP cohort have SCA, a prevalence comparable to estimates in the general population. While these men have successfully served in the military, they have higher morbidity and report poorer HRQoL with aging. Longer longitudinal follow-up of this sample will be informative for clinical and patient-reported outcomes, the role of ancestry, and mortality statistics.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>KEY POINTS<\/jats:title>\n                  <jats:list list-type=\"order\">\n                    <jats:list-item>\n                      <jats:p>Comparable to the general population, approximately 1 in 370 male veterans have a sex chromosome aneuploidy, but most are undiagnosed.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Men with X or Y chromosome aneuploidy successfully complete US miliary duty with similar service history compared to their 46,XY peers.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Medical comorbidities and healthcare utilization metrics are higher in male veterans with 47,XXY and 47,XYY during aging, however life expectancy is similar to matched controls.<\/jats:p>\n                    <\/jats:list-item>\n                  <\/jats:list>\n                <\/jats:sec>","DOI":"10.1101\/2023.07.15.23292710","type":"posted-content","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T14:15:10Z","timestamp":1689516910000},"source":"Crossref","is-referenced-by-count":2,"title":["Prevalence, Morbidity, and Mortality of 1,609 Men with Sex Chromosome Aneuploidy: Results from the Diverse Million Veteran Program Cohort"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0304-9550","authenticated-orcid":false,"given":"Shanlee M.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Teerlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan R.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana","family":"Pagadala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Panizzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria C.","family":"Merritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiju","family":"Pyarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith L.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Hauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2023071905001364000_2023.07.15.23292710v1.1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31805"},{"key":"2023071905001364000_2023.07.15.23292710v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-0837-y"},{"key":"2023071905001364000_2023.07.15.23292710v1.3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-15"},{"key":"2023071905001364000_2023.07.15.23292710v1.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2011.02274.x"},{"key":"2023071905001364000_2023.07.15.23292710v1.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-007-0365-8"},{"key":"2023071905001364000_2023.07.15.23292710v1.6","doi-asserted-by":"publisher","DOI":"10.1530\/EC-23-0024"},{"key":"2023071905001364000_2023.07.15.23292710v1.7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-1239"},{"key":"2023071905001364000_2023.07.15.23292710v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.05.011"},{"key":"2023071905001364000_2023.07.15.23292710v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.09.016"},{"key":"2023071905001364000_2023.07.15.23292710v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2019.04.012"},{"issue":"2","key":"2023071905001364000_2023.07.15.23292710v1.11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/jhrr.jhrr_10_18","article-title":"Baseline Characterization and Annual Trends of Body Mass Index for a Mega-Biobank Cohort of US Veterans 2011-2017","volume":"5","year":"2018","journal-title":"J Health Res Rev Dev Ctries"},{"key":"2023071905001364000_2023.07.15.23292710v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.03.004"},{"key":"2023071905001364000_2023.07.15.23292710v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2019.08.012"},{"key":"2023071905001364000_2023.07.15.23292710v1.14","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-2680-1"},{"key":"2023071905001364000_2023.07.15.23292710v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"2023071905001364000_2023.07.15.23292710v1.16","doi-asserted-by":"publisher","DOI":"10.1097\/00004479-200604000-00011"},{"key":"2023071905001364000_2023.07.15.23292710v1.17","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-022-00435-7"},{"key":"2023071905001364000_2023.07.15.23292710v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2022.115372"},{"key":"2023071905001364000_2023.07.15.23292710v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2022.04.019"},{"key":"2023071905001364000_2023.07.15.23292710v1.20","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.50.6.613"},{"key":"2023071905001364000_2023.07.15.23292710v1.21","doi-asserted-by":"publisher","DOI":"10.1002\/jts.22059"},{"key":"2023071905001364000_2023.07.15.23292710v1.22","unstructured":"Instructions for classifying the underlying cause of death."},{"key":"2023071905001364000_2023.07.15.23292710v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2009.09.007"},{"key":"2023071905001364000_2023.07.15.23292710v1.24","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0976-2"},{"key":"2023071905001364000_2023.07.15.23292710v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7696(08)61349-2"},{"key":"2023071905001364000_2023.07.15.23292710v1.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000263"},{"key":"2023071905001364000_2023.07.15.23292710v1.27","doi-asserted-by":"publisher","DOI":"10.1159\/000322816"},{"key":"2023071905001364000_2023.07.15.23292710v1.28","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-018-0881-3"},{"key":"2023071905001364000_2023.07.15.23292710v1.29","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.31798"},{"key":"2023071905001364000_2023.07.15.23292710v1.30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1077"},{"key":"2023071905001364000_2023.07.15.23292710v1.31","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usy410"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.07.15.23292710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:37:13Z","timestamp":1768505833000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.07.15.23292710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,16]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1101\/2023.07.15.23292710","relation":{},"subject":[],"published":{"date-parts":[[2023,7,16]]},"subtype":"preprint"}}